It is well established that patients with moderate to severe acute COVID-19 have elevated autoantibodies against type I IFNs (24), but our data suggest that autoantibodies against MDA5 upstream of type I IFN production may be involved in the pathogenesis of PASC. Here, IFIH1 is linked to COVID-19.